Diane Mcdowell Email and Phone Number
Diane Mcdowell work email
- Valid
- Valid
- Valid
- Valid
- Valid
Diane Mcdowell personal email
Diane Mcdowell phone numbers
• Fellowship trained, board certified, surgical oncologist and award winning, pharmaceutical executive with eight years of oncology and immuno-oncology experience in clinical development and medical affairs in both domestic and international markets for Global Pharmaceutical Companies. • Extensive clinical development experience which includes indication file lead, regulatory interaction on Phase I-III studies, and creation of clinical development plans. Medical Affairs experience includes Phase IV study leadership, medical matrix team creation and leadership and extensive interaction with key opinion leaders.• Excellent academic background, including extensive research and clinical experience at top tier academic and medical institutions.
-
Senior Vice President Clinical Development And Medical AffairsIo Biotech Oct 2021 - PresentCopenhagen, Denmark, Dk
-
Corporate Vice President Global Medical Affairs OncologyCelgene Oct 2018 - Apr 2021Summit, New Jersey, Us -
Head Of Global Scientific Affairs Oncology R&DGsk Mar 2017 - Sep 2018Brentford, Middlesex, Gb -
Head U.S. Medical Affairs OncologyMerck May 2015 - Dec 2016Rahway, New Jersey, Us• Build US OGMA team from 15 employees to over 40 experienced, oncology experts• Lead team of HQ strategy and field medical to develop and execute US OGMA launch plans.Launched 2nd line lung and melanoma label update for pembrolizumab in 2015. Launched MEC for Emend and HNSCC for pembrolizumab in 2016• Lead cross function collaboration to develop and execute US OGMA plan Create, implement and run best practice programs that are being replicated globally across OGMA including insights collection tool, data summary tool, and US OGMA playbook -
Director Clinical Development (Executive Band)Gsk Sep 2014 - May 2015Brentford, Middlesex, GbPhysician Leader Lung Indication and Melanoma Submission Team Tafinlar/Mekinist • Lead regulatory filing for lung indication by collaborating and participating in direct regulatory interaction with FDA and global regulatory agencies including EMA to further registration intent with a breakthrough status agent.• For major melanoma submission, directly and in collaboration with key thought leaders, hands-on author multiple study documents including clinical study reports, scientific publications, protocols and amendments as well as documents for sNDA submissions and prepare responses to questions from regulators. • Principal Medical Monitor for Phase I-III studies in clinical pharmacology, dose finding, and registrational trials. • Create and implement study designs, direct study start up, select study sites, and author and implement protocols in collaboration with principal investigators. Evaluate and respond to investigator questions, direct responses to adverse event/patient safety incidents, review clinical study data, oversee submission of data to medical meetings, and author protocol amendments and train study personnel on implementation of protocol and amendments.
-
Us Medical Affairs Lead Tafinlar/MekinistGsk Apr 2013 - May 2015Brentford, Middlesex, Gb• Leader of Medical Matrix Team, organize, recruit, and train medical affairs staff and champion emerging leaders across all GSK U.S. operations as emerging leader champion. Create and implement plan for successful launch of Tafinlar/Mekinist into US Market.• Lead cross function collaboration to develop and execute USMA plan for combination therapy: Initiate first ever Publication Development Committee to advance secondary analyses of Tafinlar/Mekinist registrational data with melanoma KEEs. Oversee and collaborate on responses to regulatory requests, including the design and implementation of an award winning response to a regulator request for a DHCPL. Create, implement and run best practice programs that were replicated by other therapeutic areas, including a One Medical Meeting for internal engagement and MSL on Demand, an external engagement strategy that received a silver award when implemented by GSK UK.• Principal Medical Monitor for Phase IV studies. Create and implement study designs, direct study start up, select study sites and author and implement protocols in collaboration with principal investigators. Evaluate and respond to investigator questions, direct responses to adverse event/patient safety incidents, review clinical study data, oversee submission of data to medical meetings, and author protocol amendments and train study personnel on implementation of protocol and amendments. • Lead Medical Affairs Support for Commercial:Advance therapeutic area understanding in melanoma by instituting first ever Congress Highlights program. Serve as Medical Point for external communications for Tafinlar/Mekinist, including interviews with industry publications, advocate and help implement first ever patient blogger summit; design and execute medical and product training of Sales Representatives; provide medical copy approval for all marketing materials.
-
Director, Oncology Global Clinical ResearchBristol-Myers Squibb Oct 2011 - Apr 2013Lawrence Township, Nj, UsMedical Monitor for Phase III lung cancer trial with ipilimumabMedical monitor for Phase II melanoma cancer trial with ipilimumabResponsible for education of other medical monitors in safety management of ipilimumab -
Director, Global Medical Affairs Lead - NecitumumabBristol-Myers Squibb Feb 2011 - Jul 2011Lawrence Township, Nj, UsLead medical affairs activitiesDevelop global medical plan and budgetDevelop publication planDevelop thought leader planMaintain relationship with JV partnersCross functional collaboration with Medical Affairs, Commercial and Access
-
Eu Markets Disease Area Head - Oncology (Interim)Bristol-Myers Squibb Jun 2010 - Jan 2011Lawrence Township, Nj, UsMatrix Manager for 25-30 employees in 23 European countries with cross functional collaboration with Medical Affairs, Commercial and AccessSupport scientific advisors with education and informationDevelop plan to safely introduce ipilimumab to Distributor Marketsipilimumab EAP educationLiaison between EU medical team and smaller countriesReview trial conceptsThought Leader management and interactions
-
Us Medical Director, - Brivanib (Interim)Bristol-Myers Squibb Jan 2010 - Jun 2010Lawrence Township, Nj, UsLead US Medical Affairs activitiesDevelop US medical plan and budgetDevelop thought leader engagement planDevelop RFP plan in collaboration with Global Medical Affairs and clinical developmentCross function collaboration with Medical Affairs, Commercial and Access
-
Director, Breast Cancer Therapeutic SpecialistBms 2007 - 2009Lawrence Township, Nj, UsUS Medical Affairs lead for launch of ixabepilone in US MarketLead US evidence generation in collaboration with Global Medical Affairs and Medical DevelopmentLead interaction with breast cancer thought leaders on ixabepilone registrational trial dataPhysician leader Bristol-Myers Squibb Foundation Medical Mission to South Africa (2008)Medical Safety team memberBiomarker team member
-
Assistant Program Director, Department Of SurgeryAbington Memorial Hospital Sep 2006 - Oct 2007Philadelphia, Pa, UsGeneral SurgeonClinical Appointments:Clinical Assistant Professor of Surgery Drexel University College of MedicineClinical Instructor in Surgery (Adjunct) Temple University School of Medicine
Diane Mcdowell Skills
Diane Mcdowell Education Details
-
Fox Chase Cancer CenterBreast Cancer -
Tulane University School Of MedicineSurgery
-
Temple University - Lewis Katz School Of MedicineMedicine
-
Penn State UniversityMicrobiology
-
Thomas Jefferson High School
Frequently Asked Questions about Diane Mcdowell
What company does Diane Mcdowell work for?
Diane Mcdowell works for Io Biotech
What is Diane Mcdowell's role at the current company?
Diane Mcdowell's current role is Senior Vice President Clinical Development and Medical Affairs at IO Biotech.
What is Diane Mcdowell's email address?
Diane Mcdowell's email address is di****@****rck.com
What is Diane Mcdowell's direct phone number?
Diane Mcdowell's direct phone number is +121575*****
What schools did Diane Mcdowell attend?
Diane Mcdowell attended Fox Chase Cancer Center, Tulane University School Of Medicine, Temple University - Lewis Katz School Of Medicine, Penn State University, Thomas Jefferson High School.
What are some of Diane Mcdowell's interests?
Diane Mcdowell has interest in Health.
What skills is Diane Mcdowell known for?
Diane Mcdowell has skills like Oncology, Clinical Development, Clinical Trials, Pharmaceutical Industry, Clinical Research, Cancer, Medicine, Medical Affairs, Drug Development, Biotechnology, Therapeutic Areas, Immunology.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial